title: Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
authors.affiliation: Center for Molecular Biology and Cytogenetics, SRL Inc., Tokyo 192-8535, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Mukaide
authors.forename: W
authors.initials: W
authors.lastname: Sugiura
authors.forename: M
authors.initials: M
authors.lastname: Matuda
authors.forename: S
authors.initials: S
authors.lastname: Usuku
authors.forename: Y
authors.initials: Y
authors.lastname: Noguchi
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: K
authors.initials: K
authors.lastname: Kawata
authors.forename: A
authors.initials: A
authors.lastname: Ito
authors.forename: H
authors.initials: H
authors.lastname: Sagara
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: M
authors.initials: M
authors.lastname: Kondo
authors.forename: M
authors.initials: M
authors.lastname: Imai
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D005821:Genetic Techniques; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000145:classification / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation
chemical_list: D019380:Anti-HIV Agents